A 42-year-old woman with a 10-year history of poorly controlled type 2 diabetes mellitus presents with sudden-onset eye pain, blurred vision, and a red eye. On examination, the cornea is hazy, and the anterior chamber is filled with blood. Intraocular pressure is 52 mmHg. Dilated fundus examination reveals multiple areas of retinal neovascularization and vitreous hemorrhage. What is the primary mechanism of glaucoma in this patient?

Explanation

## Diagnosis: Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy ### Clinical Context This patient has proliferative diabetic retinopathy (PDR) with neovascularization of the iris (NVI) and angle (NVA), leading to neovascular glaucoma (NVG). The sudden onset of pain, hyphema, and markedly elevated IOP (52 mmHg) in the setting of advanced diabetic eye disease is pathognomonic. ### Pathophysiology of Neovascular Glaucoma **Key Point:** Neovascular glaucoma develops through a two-stage mechanism: 1. **Early Stage (Open Angle):** Fibrovascular membrane grows across the angle without causing closure. The neovascular tissue secretes growth factors (VEGF, FGF) and inflammatory cytokines that: - Increase trabecular meshwork cellularity - Promote fibrosis and collagen deposition - Reduce aqueous outflow facility - Increase aqueous humor viscosity 2. **Late Stage (Angle Closure):** Contraction of the fibrovascular membrane pulls the peripheral iris forward, causing angle-closure and further IOP elevation. ### Why Hyphema Occurs in This Case The neovascular membrane is friable and bleeds easily, particularly with eye movements or minor trauma. The hyphema contributes to IOP elevation by: - Mechanical obstruction of aqueous outflow - Inflammatory cell infiltration - Trabecular meshwork damage However, the PRIMARY mechanism is the neovascular membrane itself, not the hyphema alone. ### Clinical Pearls **High-Yield:** Neovascular glaucoma is one of the most severe forms of secondary glaucoma, with a poor visual prognosis if not treated urgently. The classic triad is: 1. Neovascularization of the iris (NVI) — "rubeosis iridis" 2. Angle neovascularization (NVA) 3. Elevated IOP **Clinical Pearl:** NVG is almost always preceded by retinal ischemia (PDR, central retinal artery occlusion, ocular ischemic syndrome). VEGF from ischemic retina drives neovascularization. **Mnemonic: NVG-PDR** — **N**eovascular **G**laucoma from **P**roliferative **D**iabetic **R**etinopathy requires urgent PRP and IOP control. ### Management Algorithm ```mermaid flowchart TD A[Neovascular Glaucoma Suspected]:::outcome --> B[Confirm NVI/NVA on gonioscopy]:::action B --> C{IOP Control Achieved?}:::decision C -->|No| D[Maximal medical therapy]:::action D --> E[Prostaglandin analog + beta-blocker + CAI ± systemic acetazolamide]:::action E --> F{IOP < 21 mmHg?}:::decision F -->|Yes| G[Proceed to PRP]:::action F -->|No| H[Anti-VEGF injection + PRP]:::action G --> I[Panretinal photocoagulation]:::action H --> I I --> J{Angle Closure Developed?}:::decision J -->|Yes| K[Cyclodestructive procedure]:::urgent J -->|No| L[Monitor and follow-up]:::action ``` ### Why This Answer is Correct The neovascular membrane is the primary pathologic lesion. It obstructs aqueous outflow by: 1. Physically blocking trabecular spaces 2. Contracting and causing angle-closure in late stages 3. Secreting pro-fibrotic and pro-inflammatory mediators The hyphema is a secondary phenomenon resulting from bleeding of the friable neovascular tissue.